TipRanks
Advertisement
Advertisement

DE:UR9 Stock Latest News

Clinuvel Pharmaceuticals Updates U.S. Investors on New and Ceased Securities via Form 6-K
Company AnnouncementsClinuvel Pharmaceuticals Updates U.S. Investors on New and Ceased Securities via Form 6-K
6d ago
6K
Clinuvel Pharmaceuticals Reports Expiry of 61,272 Performance Rights
PremiumCompany Announcements
Clinuvel Pharmaceuticals Reports Expiry of 61,272 Performance Rights
7d ago
Clinuvel Seeks ASX Quotation for Additional Ordinary Shares
PremiumCompany Announcements
Clinuvel Seeks ASX Quotation for Additional Ordinary Shares
7d ago
Clinuvel urges stability ahead of AGM as board warns against potential spill
PremiumCompany Announcements
Clinuvel urges stability ahead of AGM as board warns against potential spill
11d ago
Clinuvel Shows Sustained Vitiligo Repigmentation with SCENESSE Combo Therapy
PremiumCompany Announcements
Clinuvel Shows Sustained Vitiligo Repigmentation with SCENESSE Combo Therapy
12d ago
Clinuvel Unveils ZEROKIN Single-Use Device for Controlled-Release Drug Delivery
PremiumCompany AnnouncementsClinuvel Unveils ZEROKIN Single-Use Device for Controlled-Release Drug Delivery
1M ago
6K
Clinuvel Unveils ZEROKIN Device to Target Growing Self-Injection Market
Premium
Company Announcements
Clinuvel Unveils ZEROKIN Device to Target Growing Self-Injection Market
1M ago
Vanguard Drops Below Substantial Holder Threshold in Clinuvel Pharmaceuticals
Premium
Company Announcements
Vanguard Drops Below Substantial Holder Threshold in Clinuvel Pharmaceuticals
1M ago
Clinuvel Weighs Nasdaq-Only Listing as Headquarters Shift to U.S.
PremiumCompany Announcements
Clinuvel Weighs Nasdaq-Only Listing as Headquarters Shift to U.S.
2M ago
Clinuvel Flags Key Risks as It Builds U.S.-Led Expansion
PremiumCompany Announcements
Clinuvel Flags Key Risks as It Builds U.S.-Led Expansion
2M ago
Clinuvel Confirms ASX Governance Compliance With 2026 Appendix 4G Filing
PremiumCompany Announcements
Clinuvel Confirms ASX Governance Compliance With 2026 Appendix 4G Filing
2M ago
Clinuvel Affirms ASX Governance Compliance and Highlights Diversity Gains
PremiumCompany Announcements
Clinuvel Affirms ASX Governance Compliance and Highlights Diversity Gains
2M ago
Clinuvel Declares AUD 0.05 Dividend for FY2026
PremiumCompany AnnouncementsClinuvel Declares AUD 0.05 Dividend for FY2026
2M ago
Clinuvel Leverages Decade of Profits to Fund U.S. Expansion Despite Flat FY2026 Revenue
Premium
Company Announcements
Clinuvel Leverages Decade of Profits to Fund U.S. Expansion Despite Flat FY2026 Revenue
2M ago
Clinuvel Sets Investor Webinar to Unveil 2026 Annual Results
Premium
Company Announcements
Clinuvel Sets Investor Webinar to Unveil 2026 Annual Results
2M ago
Clinuvel Advances VLRX-L Controlled-Release Injectable Peptide Platform
PremiumCompany Announcements
Clinuvel Advances VLRX-L Controlled-Release Injectable Peptide Platform
2M ago
Clinuvel steps up vitiligo push as SCENESSE data and North American rollout near
PremiumCompany Announcements
Clinuvel steps up vitiligo push as SCENESSE data and North American rollout near
3M ago
Clinuvel maps SCENESSE’s path in vitiligo with new Phase III trial
PremiumCompany Announcements
Clinuvel maps SCENESSE’s path in vitiligo with new Phase III trial
3M ago
Clinuvel Pharmaceuticals Reports Lapse of Performance Rights
PremiumCompany Announcements
Clinuvel Pharmaceuticals Reports Lapse of Performance Rights
3M ago
Clinuvel shifts headquarters to U.S. in strategic overhaul
PremiumCompany AnnouncementsClinuvel shifts headquarters to U.S. in strategic overhaul
3M ago
Clinuvel Starts Trading Level II ADS on Nasdaq Under CUVL
Premium
Company Announcements
Clinuvel Starts Trading Level II ADS on Nasdaq Under CUVL
3M ago
Clinuvel wins Health Canada approval for rare‑disease drug SCENESSE
Premium
Company Announcements
Clinuvel wins Health Canada approval for rare‑disease drug SCENESSE
3M ago

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >